SCHEMBL8725859

SCHEMBL8725859

CC(C)(C)C([C]=O)c1ccc(N(CCO)CCO)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
ATM Q13315 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CNR2 P34972 4/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
ALDH1A1 P00352 2/20 0.33
TSHR P16473 2/20 0.33
MAPT P10636 3/20 0.33
MEN1 O00255 2/20 0.33
GAA P10253 1/20 0.33
PKM P14618 1/20 0.33
HTT P42858 1/20 0.33
MCL1 Q07820 1/20 0.33
EGFR P00533 1/20 0.33
ERBB2 P04626 1/20 0.33
PPARG P37231 1/20 0.31
TDP1 Q9NUW8 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL345445 0.72 EGFR (0.49) KMT2ALMNASMN1; SMN2TP53ATM
SCHEMBL16082902 0.72 KMT2A (0.45) KMT2ALMNASMN1; SMN2TP53ATM
SCHEMBL2759014 0.72 KMT2A (0.54) KMT2ALMNASMN1; SMN2TP53ATM
SCHEMBL3893912 0.72 KMT2A (0.56) KMT2ALMNASMN1; SMN2TP53ATM
SCHEMBL6243535 0.71 MAPT (0.44) KMT2ALMNASMN1; SMN2TP53ATM
Hydrochloric Acid SCHEMBL8038931 0.69 MAPT (0.43) KMT2ALMNASMN1; SMN2TP53ATM
SCHEMBL44011 0.69 LMNA (0.43) KMT2ALMNASMN1; SMN2TP53L3MBTL1
SCHEMBL2759005 0.68 KMT2A (0.49) KMT2ALMNASMN1; SMN2TP53ATM
SCHEMBL2759029 0.68 SLC2A1 (0.50) KMT2ALMNASMN1; SMN2TP53ATM
SCHEMBL5551309 0.68 RIPK1 (0.39) KMT2ALMNAATML3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0651740-B1 AMINO ACID LINKED NITROGEN MUSTARD DERIVATIVES AND THEIR USE AS PRODRUGS IN THE TREATMENT OF TUMOURS ZENECA LTD (GB) 1998-10-21 EP disclosed
EP-0651740-A1 AMINO ACID LINKED NITROGEN MUSTARD DERIVATIVES AND THEIR USE AS PRODRUGS IN THE TREATMENT OF TUMOURS ZENECA LIMITED (GB) 1995-05-10 EP disclosed
US-5405990-A For use in antibody directed enzyme prodrug therapy; cytotoxic parent nitrogen mustard; antitumor agents ZENECA LIMITED (GB) 1995-04-11 US disclosed
WO-1994002450-A1 AMINO ACID LINKED NITROGEN MUSTARD DERIVATIVES AND THEIR USE AS PRODRUGS IN THE TREATMENT OF TUMOURS ZENECA LIMITED (GB) 1994-02-03 WO disclosed